EPIC FDA Monday, August 24, 2009 0.00 Neutral

FDA Approves Unknown Drug — EPIC PHARMA LLC

EPIC Pharma received FDA approval for Abbreviated New Drug Application ANDA090895, which positions the company to enter the generic market, potentially creating new revenue streams and increasing competitive dynamics within the respective therapeutic class.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day